Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Microsomal triglyceride transfer protein
(
MTP
) is required for the assembly and cellular secretion of apolipoprotein B (apoB) -containing lipoproteins from the liver and intestine. The secretion pattern of apoB-containing lipoproteins is likely to influence the VLDL and LDL levels in plasma. By initial opportunistic screening for polymorphic sites in the regulatory region of the
MTP
gene by gene sequencing in 20 healthy male subjects, a common functional G/T polymorphism was detected 493 bp upstream from the transcriptional start point. There was differential binding of unique nuclear proteins at this site, as shown by electrophoretic mobility shift assay. The G variant seemed to bind two or three nuclear proteins that do not bind to the T variant. Expression studies with minimal promoter constructs linked to the
chloramphenicol acetyltransferase
reporter and transfected into HepG2 cells revealed marked enhancement of transcriptional activity with the T variant. The prevalence of the
MTP
promoter genotypes was investigated in a group of 184 healthy, middle-aged white men; the frequency of homozygosity for the
MTP
-493 T variant was .06 and the allele frequency of
MTP
-493T was .25 in the population. These homozygous subjects had a 22% lower LDL cholesterol concentration than did heterozygotes or subjects homozygous for the
MTP
-493 G variant (2.9+/-0.6 versus 3.7+/-0.8 mmol/L, P<.05). Analysis of apoB and triglyceride contents in VLDL subfractions revealed a markedly changed balance within the VLDL population. Subjects homozygous for the
MTP
-493 T variant had fewer but more lipid-rich VLDL particles, thereby arguing for an effect of
MTP
expression on the hepatic secretion of triglyceride-rich, apoB-containing lipoproteins. This common genetic variation of the
MTP
promoter is likely to have important implications for cardiovascular disease.
...
PMID:A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. 1529 89